370 related articles for article (PubMed ID: 29666782)
1. New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.
Rossini M; Rizzo P; Bononi I; Clementz A; Ferrari R; Martini F; Tognon MG
Front Oncol; 2018; 8():91. PubMed ID: 29666782
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review.
Lo Russo G; Tessari A; Capece M; Galli G; de Braud F; Garassino MC; Palmieri D
Front Oncol; 2018; 8():650. PubMed ID: 30622932
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of malignant pleural mesothelioma.
Jaurand MC; Fleury-Feith J
Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
[TBL] [Abstract][Full Text] [Related]
4. Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge.
Abbott DM; Bortolotto C; Benvenuti S; Lancia A; Filippi AR; Stella GM
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32392897
[TBL] [Abstract][Full Text] [Related]
5. Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.
Lee LJ; Lin CK; Pan CH; Cheng Y; Chang YY; Liou SH; Wang JD
BMJ Open; 2018 Dec; 8(12):e021063. PubMed ID: 30530573
[TBL] [Abstract][Full Text] [Related]
6. Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres.
Proietti L; Spicuzza L; Di Maria A; Polosa R; Sebastian Torres E; Asero V; Di Maria GU
Monaldi Arch Chest Dis; 2006 Dec; 65(4):210-6. PubMed ID: 17393666
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
Kim K; Ko Y; Oh H; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Heo HJ; Kim G; Kim JW; Kim YH
J Toxicol Environ Health A; 2020 Feb; 83(3):126-134. PubMed ID: 32114955
[TBL] [Abstract][Full Text] [Related]
8. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey.
Senyiğit A; Babayiğit C; Gökirmak M; Topçu F; Asan E; Coşkunsel M; Işik R; Ertem M
Respiration; 2000; 67(6):610-4. PubMed ID: 11124642
[TBL] [Abstract][Full Text] [Related]
9. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.
Demir M; Kaya H; Taylan M; Ekinci A; Yılmaz S; Teke F; Sezgi C; Tanrikulu AC; Meteroglu F; Senyigit A
Lung; 2016 Jun; 194(3):409-17. PubMed ID: 27032653
[TBL] [Abstract][Full Text] [Related]
11. Missed opportunities to counsel patients with malignant pleural mesothelioma about causation and potential compensation.
Kuschner WG; Varma R; Flores R; Agrawal M; Guvenc-Tuncturk S
Am J Med Sci; 2012 Mar; 343(3):206-9. PubMed ID: 21817877
[TBL] [Abstract][Full Text] [Related]
12. Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives.
Cavallari I; Urso L; Sharova E; Pasello G; Ciminale V
Front Oncol; 2019; 9():740. PubMed ID: 31475103
[TBL] [Abstract][Full Text] [Related]
13. [Malignant pleural mesothelioma in patients hospitalised at the Clinical Hospital Centre Rijeka between 1989 and 2008].
Kricka O; Matanić Lender D; Barković I; Flego V; Kupanovac Z; Bulat Kardum L
Arh Hig Rada Toksikol; 2009 Nov; 60 Suppl():41-3. PubMed ID: 20853777
[TBL] [Abstract][Full Text] [Related]
14. Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma.
Yilmaz UM; Utkaner G; Yalniz E; Kumcuoglu Z
Respirology; 1998 Mar; 3(1):33-8. PubMed ID: 9657657
[TBL] [Abstract][Full Text] [Related]
15. Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma.
Scherpereel A;
Respir Med; 2007 Jun; 101(6):1265-76. PubMed ID: 17137779
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma.
Zekri AR; Bahnassy AA; Mohamed WS; Hassan N; Abdel-Rahman AR; El-Kassem FA; Gaafar R
Pathol Int; 2007 Aug; 57(8):493-501. PubMed ID: 17610473
[TBL] [Abstract][Full Text] [Related]
17. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.
Zhang W; Wu X; Wu L; Zhang W; Zhao X
Ann Transl Med; 2015 Aug; 3(13):182. PubMed ID: 26366399
[TBL] [Abstract][Full Text] [Related]
18. [Malignant pleural mesothelioma: diagnosis and treatment].
Delourme J; Dhalluin X; Cortot AB; Lafitte JJ; Scherpereel A
Rev Pneumol Clin; 2013 Feb; 69(1):26-35. PubMed ID: 23333048
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
Rodríguez Portal JA; Rodríguez Becerra E; Rodríguez Rodríguez D; Alfageme Michavila I; Quero Martínez A; Diego Roza C; León Jiménez A; Isidro Montes I; Cebollero Rivas P
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):646-50. PubMed ID: 19190155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]